Established in 2005, Pradama Inc. is a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing proprietary bone-targeting drug delivery technology. Pradama’s goal is to develop multiple products through a combination of internal product development and strategic partnerships with leading pharmaceutical companies. The Company is currently focused on a proprietary drug development program in osteoporosis; orally available anabolic agents for osteoporosis. Additional indications will include osteomyelitis and bone cancer. Current investors include Kentucky Seed Capital Fund and Triathlon Medical Ventures. A Delaware C corporation, Pradama is located in Louisville, Kentucky.